Medical Management Guided by Pulmonary Artery Pressures in NYHA Functional Class III Heart Failure Patients

Costanzo, María Rosa; Abraham, William T.; Adamson, Philip B.; Cowart, Pam; Corcoran, K; Ginn, Greg

doi:10.1016/j.cardfail.2011.06.313

Cited by 2 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Few studies have included HF patients with preserved EF, which account for approximately half of ADHF hospitalisations 58. Data from CHAMPION and COMPASS studies point to a similar benefit for HF patients with preserved versus reduced EF 33 37 38…”

Section: Discussionmentioning

confidence: 99%

“…We still do not know from several published trials whether knowledge of fluid status data actually led to medication changes; specifically, to enhanced use of drugs known to reduce morbidity and mortality in HF. The medical community needs to learn what specific medication changes produced results superior to standard care, as recently reported for the CHAMPION study 38 56. Next, exactly how were the fluid status data translated into treatment decisions?…”

Section: Discussionmentioning

confidence: 99%

“…The specific medication changes by which the encouraging results of the CHAMPION trial were achieved deserve further discussion 56. PAP guided HF therapy led to significantly greater utilisation of nitrates, ACEI/ARBs and β blockers 38. Diuretics were frequently adjusted, but not differently between groups.…”

Section: Emerging Strategies To Monitor Fluid Status In Hfmentioning

confidence: 99%

See 2 more Smart Citations

Current modalities for invasive and non-invasive monitoring of volume status in heart failure: Table 1

Lueder

Krum

2012

Heart

View full text Add to dashboard Cite

Heart failure (HF) represents a major health and economic burden worldwide. In spite of best current therapy, HF progresses with unpredictable episodes of deterioration that often require hospitalisation. These episodes are often preceded by accumulation or redistribution of fluid causing haemodynamic overload on the heart. Remote and telemonitoring of the HF patient, assessing symptoms and signs, thoracic impedance derived fluid status follow-up or direct haemodynamic measurements with chronic implanted devices are presently under investigation for the potential to detect impending HF decompensation early. The current evidence for volume status monitoring in HF using those novel management strategies is reviewed.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%